Novavax Stock Plunges 25% As Vaccine Maker Has ‘Substantial Doubt' About Staying In BusinessForbes • 03/01/23
Novavax Reports Fourth Quarter and Full Year 2022 Financial Results and Operational HighlightsPRNewsWire • 02/28/23
Here's The Good News For Novavax Ahead Of Its Fourth-Quarter ReportInvestors Business Daily • 02/28/23
3 Supercharged Growth Stocks Down 89% to 97% That Billionaires Can't Stop BuyingThe Motley Fool • 02/23/23
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 28, 2023PRNewsWire • 02/21/23
Novavax Plans To Update Its Covid Shot — But Is NVAX Stock A Buy Today?Investors Business Daily • 02/16/23
NVAX Stock Alert: Novavax Will Provide 1.5 Million More Covid-19 Vaccine Doses to U.S.InvestorPlace • 02/13/23
Novavax to provide up to 1.5 million more doses of its COVID-19 vaccine to the U.S.Market Watch • 02/13/23
U.S. Government and Novavax Extend Partnership, Securing Up to 1.5 Million Additional Doses of Novavax' COVID-19 VaccinePRNewsWire • 02/13/23
Novavax (NVAX) COVID Jab Aids Growth, Overdependence a Challenge (revised)Zacks Investment Research • 01/27/23